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T
here is an increasing gap worldwide between 
the demand for and supply of kidneys for trans-
plantation, and the situation in Canada is no ex-
ception.1 In most North American and European coun-
tries, the number of deceased-donor kidneys available 
for transplant is insufficient to meet the need. Among the 
measures that have been implemented to alleviate this 
shortage are (1) widening the eligibility criteria for de-
ceased-donor organs; (2) procuring organs after cardiac 
death; (3) expanding the pool of living donors to include 
altruistic donors; and (4) developing exchange programs 
for incompatible donor/recipient pairs. This fourth scen-
ario (the focus of this article) pertains to cases in which 
a prospective living donor proves not to be a match for 
the intended recipient. Two such pairs can be “linked” 
when Donor 1 cannot donate to Recipient 1, but can do-
nate to Recipient 2, and Donor 2 cannot donate to Recipi-
ent 2, but can donate to Recipient 1. Variations on this 
exchange include “domino” or chain exchanges involving 
more than two donor/recipient pairs.2 
Interest in this type of living-donor organ donation is 
growing, and some researchers have estimated that such 
exchanges could result in 1000 to 2000 additional renal 
transplants  being  performed  annually  in  the  United 
States.3 In Canada, there were no exchange programs 
before 2009, when Canadian Blood Services launched 
the Living Donor Paired Exchange Registry.4 Initially, 3 
provinces were involved (Alberta, British Columbia and 
Ontario), and now all provinces are part of the exchange 
program. Quebec was the last province to join, in No-
vember 2010. The first domino exchange in Canada took 
place in June 2009.4 In the first 18 months of the pro-
gram, 107 pairs were registered and 65 transplants were 
proposed (as of August 2010, 39 of the proposed trans-
plants  had  been  completed,  9  were  under  review  and 
17 had been cancelled) (Dr. Peter Nickerson, Executive 
Medical  Director  (Transplantation)  Organ  and  Tissue 
Division, Canadian Blood Services; personal communi-
cation, 2010). To date, donors participating in the pilot 
project have travelled to recipients’ respective transplant 
centres. We might question, however, whether in a coun-
try such as Canada we should be “shipping” the donor, 
or the kidney. It could be argued that this question is ir-
relevant, and that paired-exchange programs should be 
regionalized (e.g., at the provincial level) to maintain ef-
ficiency and reduce the burden of travel for donors. How-
ever,  considering  that,  to  function  properly,  exchange 
programs are estimated to require a population of over 
15 million (to have sufficient potential donors), and that 
increasing the pool of pairs significantly increases the 
chances of finding a compatible donor for hard-to-match 
recipients, provincial or regional programs might not be 
the best option.5
Arguments for donor travel
Traditionally,  most  exchange  programs  have  involved 
the donor travelling to the recipient’s transplant centre 
to reduce the cold ischemia time—one of the reasons in-
voked for the better long-term outcomes of living-donor 
as  compared  with  deceased-donor  renal  transplanta-
tion. However, two recent case reports from the United 
States on domino kidney transplantation that involved 
shipping organs via a commercial airline or private jet 
showed good renal transplant function despite the long-
er cold ischemia time (between 8 and 14 hours).6,7 It is 
important to note that one of the recipients of a shipped 
kidney  had  a  high  titer  of  preformed  anti-HLA  anti-
bodies, which made her a difficult match and at higher 
risk of acute rejection. 
A retrospective study conducted by Simpkins and col-
leagues  found  excellent  outcomes  of  living-donor  kid-
ney transplantation with cold ischemia times of up to 8 
hours.8 The authors concluded that the transport of or-
gans from living donors is feasible if the cold ischemia time is limited to 8 hours.8 However, it is important to 
bear in mind that 85% of living-donor kidneys had less 
than 2 hours of cold ischemia time, and that data on trans-
plant outcomes for cold ischemia times of more than 8 
hours are limited. A large retrospective study7 using the 
United Network for Organ Sharing Kidney Transplant 
Registry compared medical outcomes of renal allograft 
from  healthy  deceased  donors  (average  cold  ischemia 
time of 18.3 hours), and from living organ donors (aver-
age cold ischemia time of 2.4 hours), and found similar 
rates of graft survival at 3 years in both groups (85.7% v. 
87.8%). The authors concluded that cold ischemia time 
did not significantly influence medical outcomes, and 
thus supported the shipment of kidneys.9 Further stud-
ies are nonetheless needed to investigate the impact of 
cold ischemia times (especially of more than 8 hours) on 
living-donor kidney transplantation.
Another argument in favour of shipping the donor 
instead of the kidney is that the team involved in pro-
curement is also the transplanting team, which could 
make the procedure more efficient. In the case of de-
ceased-donor organ donation, however, kidneys are not 
necessarily procured by the same team conducting the 
transplant; this does not seem to be problematic, since 
the  technique  for  deceased-donor  organ  donation  is 
standardized. Finally, an important argument in favour 
of shipping the donor is a logistical one. Given the six 
time zones within Canada, it is quite likely that some 
transplant surgeries would occur outside normal work-
ing hours, in order to minimize cold ischemia time; hav-
ing the donor on site would eliminate this concern.
Arguments for shipping the kidney
There are some important advantages in shipping the 
kidney instead of the donor. First, because the two in-
compatible pairs are likely to be in different hospitals, it 
is easier to maintain the anonymity this affords by ship-
ping the organs. A study conducted in the Netherlands 
showed that anonymity was an essential condition for 
the participation of potential incompatible pairs in ex-
change programs.10 Second, shipping the kidney to the 
recipient’s transplant centre allows the donor to remain 
in a familiar setting, surrounded by family and friends, 
thus receiving the support that is essential throughout 
the donation and transplantation process.11 
Now that Quebec has joined the Living Donor Paired 
Exchange Registry, language will also become an issue: 
79% of the Quebec population speak French, whereas 
English is the predominant language in the rest of Can-
ada.12 If a unilingual francophone donor were to travel 
to a recipient’s transplant centre outside Quebec, he or 
she might not be able to receive care in French, which 
would potentially compromise the quality of the trans-
plantation experience. Similar situations are imaginable 
in, for example, the United States (e.g., with regard to 
Spanish speakers) or in European countries, where there 
are  significant  linguistic  minorities,  especially  among 
first-generation immigrants. However, there is no litera-
ture describing the impact of linguistic factors on trans-
plantation outcomes.
One  cannot  underestimate  the  importance  of  the 
trust  relationship  established  between  the  donor  and 
transplant professionals during the living-organ donor 
assessment. Deciding to donate an organ to a stranger—
even if the end result is an available organ for a loved 
one—is still an emotionally and psychologically difficult 
decision for many people, and one that requires a sup-
portive clinical environment. This does not mean that 
other transplant centres will not offer professional and 
supportive care. But, when one considers that a trans-
plantation  team  will  be  responsible  for  the  long-term 
follow-up care of living organ donors, there is even more 
reason for the latter to remain with a medical team they 
know and trust. 
Conclusion
The  first  domino  exchanges  in  Canada  involved  the 
donor travelling to the recipient’s transplant centre; to 
date, there have been no reports of adverse events or dis-
satisfaction resulting from this arrangement. These re-
sults are similar to those reported in the Netherlands, 
the United States and South Korea, the three countries 
that have had the most experience with exchange pro-
grams. That being said, these countries do not have the 
same  linguistic  characteristics  as  Canada,  and  two  of 
the three are geographically much smaller, which makes 
the shipping of organs easier and the cold ischemia time 
shorter. 
An important and potentially determinative factor in 
paired-exchange programs is the travel and associated 
costs of the two alternatives (i.e., shipping the kidney, or 
the donor). Currently, no Canadian data are available to 
enable cost comparisons. Such an analysis would also 
have to take into account variations among provincial 
reimbursement programs for living donors’ travel and 
living  expenses.  Some  provinces  currently  reimburse 
donors’  for  their  travel  expenses;  others  do  not.  Now 
that Canadian Blood Services has launched a national 
exchange program, a detailed cost analysis will be es-
sential to the development of rational, equitable policies.
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donors to stay in a transplant centre and be cared for by 
a team they know and trust, and to be close to their loved 
one/recipient, family and friends. However, it is not un-
reasonable to assume that some potential living organ 
donors will be willing to travel to another province with 
the aim of reducing cold ischemia time and maximiz-
ing  transplantation  outcomes  (even  though  conclusive 
evidence on the impact of cold ischemia times on the 
outcomes of living renal transplantation is still lacking). 
Thus, although we favour transporting the organ rather 
than the donor, both options should still be offered to 
potential living organ donors participating in exchange 
programs.
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